While secondary erythrocytosis is often associated with tumors arising from the kidney, other tumors have been described to originate in the liver, uterus, ovary, adrenal gland, and central nervous system, among which cerebellar hemangioblastomas are involved in most instances. Two cases of meningioma associated with erythrocytosis have already been reported. We observed a 59-year-old female patient who had developed a frontal meningioma associated with erythrocytosis. Before surgery, she had a significantly elevated total red blood cell volume with a normal plasma volume. Serum erythropoietin (Epo) dosage assessed by radioimmunoassay was within the normal range. The tumor RYTHROPOIETIN (Epo) is the hormone that controls E erythropoiesis in mammals. It is produced mainly in the kidney, where oxygen tension is its regulating physiologic factor.' I n rare instances, tumors can induce excessive unregulated Epo production, resulting in secondary erythrocytosis. Among these tumors, renal cell carcinomas account for most case^,^.^ whereas nephroblastomas are very rare.5
gioma associated with erythrocytosis in which Epo production was assessed by Northern blot analysis as well as in situ hybridization, and was found to be localized within the tumor cells.
CASE REPORT
A 59-year-old Caucasian woman presented with headache, personality change, and left facial palsy. The CT scan found a 5-cm large, well-limited frontal tumor, exerting a mass effect on the ventricles and cerebral structures. At angiography, the tumor showed a welldeveloped vascularization. In this noncigarette-smoking patient, the hemoglobin level was 18 g% and the hematocrit was 53%. A chromium-51 red blood cell (RBC) volume study showed an elevated RBC volume of 2,785 mL (calculated theoretical upper limit of normal size and gender, 1,958 mL), whereas the plasma volume assessed by iodine-125 was normal. The RBC volume determination in milliliters per kilogram was not reliable in this overweight patient ( I I3 kg/163 cm height)." Serum Epo dosage assessed by radioimmunoassay (RIA) was within the normal range (16 mU/mL; normal values, 5 to 20 mU/mL). The tumor was surgically removed, the postoperative course was uneventful, and the hemoglobin level returned to normal.
Tumor tissue was obtained at surgery. One part was fixed in formalin for pathologic examination and the other part was immediately frozen in liquid nitrogen and stored at -80°C until use for Northern blot analysis, in situ hybridization, and immunohistochemistry.
MATERIALS AND METHODS

Probe
The Epo probe used was a 642-bp Kpn I-Bgl 11 insert of Epo monkey cDNA.I9 This probe was 32P-or 35S-labeled using the random priming method." was removed and the pathologic study found a meningotheliomatous meningioma. Total RNA from the tumor was hybridized to a monkey cDNA Epo probe. A strong 1.6-kb messenger RNA (mRNA) signal was observed, which is the expected size of human Epo mRNA. In situ hybridization with the 35S-labeled Epo probe was performed on frozen tumor tissue sections. A significant hybridization was observed in all the tumor cells, whereas the stroma was negative. Therefore, in this meningioma associated with erythrocytosis, Epo was produced by the tumor cells themselves.
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RNA Extraction and Northern Blot Analysis
Frozen tissues from the tumor were crushed to a powder and homogenized in 4 mol/L guanidine thiocyanate. Total RNAs were extracted by the method of Chirgwin et al.*' After glyoxal denaturation, 20 pg of total RNA was electrophoresed and transferred to a nylon membrane, and the blotted RNAs were hybridized to the "P-labeled Epo probe.
For positive control, RNA extracted from a well-characterized Eposecreting renal cell cance?2 were hybridized in parallel with the Epo probe.
In Situ Hybridization
Five-micrometer thick sections of unfixed frozen tumor tissue were prepared. They were fixed in 4% formalin in phosphate-buffered saline (PBS; 0.1 mol/L, pH 7.4) for 5 minutes and dehydrated in graded alcohols without a permeation step. Except for slight modifications, the in situ hybridization procedure has been previously described.22 Briefly, tissue sections were hybridized under a sealed coverslip overnight at 45°C in 15 pL of a solution containing 40% deionized formamide; 4X standard saline citrate (SSC), pH 6.2; 0.02% Ficoll; 0.02% polyvinylpyrrolidone; 0.02% bovine serum albumin; 10% dextran sulfate; 2 mg/mL yeast tRNA (Sigma, St. Louis, MO); 400 pg/mL salmon sperm DNA (Sigma); 400 pg/mL hemng sperm DNA (Sigma); 10 mmol/L dithiothreitol; and 0.2 ng/pL of the 35S-radiolabeled probe (specific activity, 2 X 10' cpmlpg) denatured at IOO"C for 2 minutes. Slides were rinsed twice at 45°C with gentle agitation in 40% formamide4X SSC for 15 minutes, followed by a rinse in 4X SSC at 60°C for 30 minutes, and then three times in 2X SSC at room temperature for I5 minutes. Sections were dehydrated in graded alcohols and dipped in Kodak NTB2 emulsion (Rochester, NY) for autoradiography. After 10 to 12 days of exposure, the slides were developed in Kodak D19, fixed in Kodak A44, and stained with hematoxylin and eosin. Frozen meningioma and Epo-secreting renal adenocarcinoma tissue sections were fixed in cold acetone and rinsed in PBS. They were incubated for 30 minutes with a rabbit polyclonal antibody against human recombinant Epo raised in our laboratory diluted at 1/10. 1/100. or 1/500. and shown with a peroxidase-antiperoxidase technique.
Epo iininimohi.~toclteini.~tr~.
RESULTS
Pathologic Diagnosis
The tumor cells were arranged in nests of cellular whorls without psammoma bodies. They had an abundant eosinophilic cytoplasm and presented neither nuclear atypia nor mitosis. The tumor stroma was well vascularized without inflammatory cells. This histopathologic pattern was consistent with the diagnosis of meningotheliomatous meningioma. 
Epo inewnger RNA (in RNA) Expression in Tumor Tissiier
A strong hybridization signal was detected with the monkey Epo probe on the RNAs extracted from both the meningioma (Fig I. lane I ) and one Epo-secreting renal adenocarcinoma previously described" and used as a control (Fig I , lane 2) . The Epo mRNA seemed to be normal sized. In the meningioma, the Epo signal was even stronger than in the renal cell carcinoma.
Localizalion of Epo-Producing Cells by In Situ Hybridirat ion
A specific hybridization signal was observed in all the tumor cells (Fig 2) , whereas the vessels remained negative. The intensity of the signal within individual tumor cells was heterogeneous, as usually observed in tumors hybridized with radiolabeled probe^.^^.^^ A strong signal was also observed with the Epo probe in the Epo-producing renal adenocarcinoma sections, which were used as a positive control (data not shown). The specificity of the signal was demonstrated by the negativity of hybridization using the renin probe and after ribonuclease treatment (Fig 3) .
Iinmiinoliisrc~chemical Studies
The meningioma tumor cells were labeled solely with the anti-vimentin antibody and not with anti-neuron-specific enolase, anti-protein S 100 or anti-cytokeratin antibodies.
The tumor cells from both the meningioma and the Epoproducing renal adenocarcinoma remained negative with the anti-Epo antibody.
DISCUSSION
This patient presented with a frontal meningioma associated with erythrocytosis. The erythrocytosis was assessed by the increase in RBC volume with a normal plasma volume. The occurrence of erythrocytosis is very uncommon in cerebral meningiomas, with only two prior cases reported?." This contrasts with cerebellar hemangioblastomas, in which erythrocytosis has been reported in up to 20% of the cases.I3 Hemangioblastomas have been shown to contain cells that stain positively for Epo using immunohist~chemistry.~~,~~ Given these published data on the one hand and the very strong Epo mRNA signal observed in the meningioma on the other, immunohistochemistry was performed as suggested by Rich?' The results of our attempts to localize Epo protein within tumor cells by immunohistochemistry remained negative. It is likely that in meningioma cells, Epo is being secreted at a very rapid rate and cannot be detected by a specific antibody.
As usually described, resolution of this erythrocytosis occurred
In the two previous reports of meningiomas associated with erythrocyt~sis?~~ the tumors had features similar to our case, such as supratentorial location and meningotheliomatous classification. However, despite the evidence of erythropoietic activity in the tumor extracts from the two cases, no direct demonstration of Epo synthesis was established. In the present report, the detection of Epo mRNA by Northem blot analysis of the RNAs extracted from the tumor and the labeling of the tumor cells evidenced by in situ hybridization with the Epo probe support the hypothesis of Epo synthesis by the tumor itself. Recently, Trimble et a129 clearly showed that, in a case of hemangioblastoma associated with erythrocytosis, the tumor produced Epo mRNA. However, the cell type, ie, stromal or vascular cells, responsible for this synthesis was not determined. The investigators described an elevated Epo level in the cyst fluid, but could not detect any elevation of the Epo in the serum. Likewise, our patient's serum Epo level was within the normal range, but, as previously described," this does not exclude the diagnosis of secondary erythrocytosis. We previously demonstrated Epo mRNA production by the tumor cells themselves in renal cell carcinomas associated with erythrocytosis.22 The precise mechanism of Epo gene activation is not understood. Indeed, neither Epo gene rearrangement nor abnormal size of the tumor Epo mRNA were reported.22 Moreover, this "ectopic" Epo production in the kidney was due to tumor cells derived from proximal tubular cells, whereas we3' and others32 showed that, in the mouse kidney, peritubular cells were the physiologic site of Epo synthesis. This "ectopic" site of Epo secretion by malignant kidney cells might be due to a derepression of the Epo gene induced by the malignant transformation. In meningiomas, tumor cells are derived from meningothelial cells, the characteristic resident cell of the leptomeninges, which are neither physiologically nor ontogenically involved in Epo synthesis. Moreover, the large majority of meningiomas follow a benign clinical course and are permanently cured by surgical excision; consequently, they are not considered to be malignant tumors. Thus, abnormal Epo gene expression might occur in tumor cells regardless of whether the tumor is benign or malignant.
